January 9, 2019
Kyorin Pharmaceutical initiated on January 7 a voluntary recall of the anti-allergic Desalex (desloratadine), for which the company has exclusive distribution rights in Japan, following a decision made by MSD, the marketing authorization holder for the agent, Kyorin Holdings said...read more